Clinical Trials in San Francisco

Showing 9701-9720 of 12,991 trials

Evaluation of GSK561679 in Women With Post-Traumatic Stress Disorder

NCT01018992

This study will test the hypothesis of whether an antagonist at the corticotropin releasing factor type 1 (CRF1) receptor (i.e. GSK561679) is superior to placebo in reducing symptoms of post-traumatic stress disorder (PTSD).

Stress Disorders, Post-Traumatic

Emory University267 participantsStarted Dec 2009

San Francisco, California, United States • Atlanta, Georgia, United States • New York, New York, United States +1 more locations

COMPLETEDPhase 1/2< 1 mile

A Study Evaluating IPI-926 in Combination With Gemcitabine in Patients With Metastatic Pancreatic Cancer

NCT01130142

Study IPI-926-03 is a Phase 1b/2 clinical trial to evaluate IPI 926 in combination with gemcitabine in patients with previously untreated metastatic pancreatic cancer. Phase 1b is designed as a dose escalation study. Once the maximum tolerated dose of IPI-926 in combination with gemcitabine is established in the Phase 1b portion of the study, the Phase 2 portion will commence. Phase 2 is designed as a randomized, double-blind (investigator/patient), placebo-controlled study. There is no cross-over option for patients in either arm of the Phase 2 (i.e., there is no option for patients receiving placebo to cross-over to IPI-926).

Metastatic Pancreatic Cancer

Infinity Pharmaceuticals, Inc.122 participantsStarted Apr 2010

Tucson, Arizona, United States • San Diego, California, United States • San Francisco, California, United States +25 more locations

Evaluation of GSK561679 in Women With Post-Traumatic Stress Disorder

A Study Evaluating IPI-926 in Combination With Gemcitabine in Patients With Metastatic Pancreatic Cancer

Find Trials by Condition in San Francisco

A Study Exploring Two Treatment Strategies in Patients With Atrial Fibrillation Who Undergo Catheter Ablation Therapy

A Trial Comparing the Efficacy, Patient-reported Outcomes and Safety of Insulin Degludec 200 U/mL vs Insulin Glargine in Subjects With Type 2 Diabetes Mellitus Requiring High-dose Insulin

Comparison of Two Insulin Degludec Formulations in Subjects With Type 2 Diabetes Mellitus

The Effect of Liraglutide Versus Placebo When Added to Basal Insulin Analogues With or Without Metformin in Subjects With Type 2 Diabetes

Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes

The Effect of Insulin Detemir in Combination With Liraglutide and Metformin Compared to Liraglutide and Metformin in Subjects With Type 2 Diabetes

The Effect of Liraglutide Compared to Sitagliptin, Both in Combination With Metformin on Glycaemic Control in Subjects With Type 2 Diabetes Mellitus

The Effect of Somatropin Treatment in Adult Patients on Chronic Dialysis

Comparison of the Efficacy and Safety of Two Intensification Strategies in Subjects With Type 2 Diabetes Inadequately Controlled on Basal Insulin and Metformin

PRESERVE-Zenith® Iliac Branch System Clinical Extended Study

PRO 140 for Human Immunodeficiency Virus Infection

Lapatinib and Radiation for Stage III-IV Head and Neck Cancer Patients Who Cannot Tolerate Concurrent Chemotherapy

Study of Oxaliplatin/5-FU/Leucovorin Plus Vatalanib Versus Oxaliplatin/5-FU/Leucovorin in Patients With Previously Treated Metastatic Colorectal Cancer

Expanded Access Study of Alectinib for Participants With Anaplastic Lymphoma Kinase (ALK)-Rearranged Non-Small Cell Lung Cancer (NSCLC) After Disease Progression on or Intolerance to Prior ALK Tyrosine Kinase Inhibitor Therapy

SuperNOVA Clinical Stenting Trial

Haemophilia Patients With Inhibitors Being Treated for Acute Joint Bleeds

Radiation Therapy or Observation After Chemotherapy in Treating Patients With Stage IV Non-Small Cell Lung Cancer

Multi-national Study Investigating the Effect and Safety of rFXIII on Transfusion Needs in Patients Undergoing Heart Surgery